As part of the Department-wide effort to combat the ongoing opioid crisis,
the Centers for Medicare & Medicaid Services is providing additional
flexibilities to help states improve access to and quality of substance use
disorder treatment through Medicaid 1115 demonstrations. This revised
policy will take the place of the initiative announced in the State Medicaid
Directors’ letter issued on July 27, 2015. With this new policy, CMS’s main goal is to support state initiatives to improve access to treatment by requiring less upfront administrative process barriers for approvals of state initiatives. This is a significant step to help states address the immediate treatment needs of individuals and families as well as providers that are on ground zero of the crisis. Through this new policy, we also hope to work with states to better understand the opioid crisis and the most effective ways to respond. This focus on outcomes will help us guide state efforts to tackle this epidemic. The letter is available online on Medicaid.gov at http://www.medicaid.gov/federal-policy-guidance/federal-policy-guidance.html For more information on Substance Use Disorders, visit https://www.medicaid.gov/medicaid/benefits/bhs/index.html |
To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
Wednesday, November 1, 2017
As part of the Department-wide effort to combat the ongoing opioid crisis...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment